Silverstein Foundation
  • About
    • Scientific Advisory Board
    • Board of Trustees
  • Initiatives
    • Partnership with MJFF
  • In the News
Select Page

Silverstein Foundation Annual Update

Vanqua Bio closes $85 million Series B financing

Silverstein Foundation Announces Grant Funding to AcureX Therapeutics.

Prevail Announces First Patient Dosed

Prevail Therapeutics Acquired by Lilly

« Older Entries
© 2019, The Silverstein Foundation for Parkinson's with GBA
Ansonia Station | P.O. Box 237137 | New York, NY 10023
INFO@SILVERSTEINFOUNDATION.ORG
  • Home
  • Contact Us
  • Privacy Policy